Latest University of Rochester Medical Center Stories
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly
Session to Examine How University of Rochester Medical Center Approached the Charity Challenge Waltham, MA (PRWEB) October 09, 2014 Connance, Inc.
A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson's disease.
A new study shows that a neurologist in an office thousands of miles away can deliver effective specialized care to people with Parkinson's disease.
A study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure.
A team from the University of Rochester Medical Center has shown scientifically what many women report anecdotally: that the breast cancer drug tamoxifen is toxic to cells of the brain and central nervous system, producing mental fogginess similar to "chemo brain."
Consumer satisfaction surveys of nursing home residents and their families track closely with other quality of care measures.
Scientists are scrambling to gather data for the FDA to support the need for a blood test to diagnose brain injury in the United States.
As baby-boomers age and the number of people with serious chronic illnesses continues to rise, the demand for experts in palliative medicine is sure to outstrip the supply.
Most scientists are starting to agree that repeat, sub-concussive hits to the head are dangerous and linked to neurological disorders later in life.